semaglutide autoinjector multidose pen‐injector with the NovoFine® Plus 32G × 4 mm and a shorter life Semaglutide vs. Ozempic: What's the

We want to help companies adjust to this shift as its happening

That part is not in question

More recently, the open label, non-inferiority trial (REDEFINE-4), comparing CagriSema to tirzepatide showed more disappointment when patients on CagriSema showed up to 23% weight loss compared to Tirzepatide that showed 25.5%

But Retatrutide, developed by Eli Lilly, has just posted the highest weight loss figure ever recorded for any anti-obesity medication in a Phase 3 clinical trial: 30.3% of body weight at 104 weeks

Interestingly, around 80% of therapeutic peptides are prepared using bacteriostatic water

One vial, four weeks, done